{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T14:27:41Z","timestamp":1777300061658,"version":"3.51.4"},"reference-count":20,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2013,4,8]],"date-time":"2013-04-08T00:00:00Z","timestamp":1365379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cathet Cardio Intervent"],"published-print":{"date-parts":[[2013,7]]},"abstract":"<jats:p>Objectives: To compare the practical use, safety, and clinical outcomes associated with the TandemHeart (TH) versus Impella Recover 2.5 (IR2.5) devices when used for circulatory support during high\u2010risk percutaneous coronary intervention (PCI). <jats:styled-content>Background<\/jats:styled-content>: Small studies and registries suggest safety and efficacy for the TH and IR2.5 percutaneous\u2010left ventricular assist devices (P\u2010LVADs). However, these P\u2010LVADs differ markedly in their insertion, operation, and manner of circulatory augmentation. To date, no study has compared these devices. <jats:styled-content>Methods<\/jats:styled-content>: We identified 68 patients (49 males, 19 females; age 71.1 \u00b1 12.1 years) from our single\u2010center database that underwent \u201chigh\u2010risk\u201d PCI with P\u2010LVAD support from April 2005 to June 2010 (32 with TH, 36 with IR2.5). Relevant data were extracted for analysis. <jats:styled-content>Results<\/jats:styled-content>: Baseline demographics were similar, including low LVEF (overall mean 31.0 \u00b1 13.7%) and elevated STS mortality risk score (4.2 \u00b1 3.7%). Angiographic characteristics were also similar, with a mean of 2.4 \u00b1 1.0 lesions treated per patient, and 29% undergoing left main PCI. PCI success rates were 99% in both groups, with similar in\u2010hospital outcomes and a combined 7% major vascular access site complication rate. A single episode of left atrial perforation occurred during TH use. No patient required emergent CABG and no in\u2010hospital deaths occurred. The 30\u2010day MACE rate (death, myocardial infarction, target lesion revascularization) was 5.8%. There were no differences between the IR2.5 and TH groups with respect to short\u2010 or long\u2010term clinical outcomes. Conclusions: The IR2.5 and TH assist devices are safe, equally effective, and associated with acceptable short\u2010 and long\u2010term clinical outcomes in patients undergoing \u201chigh\u2010risk\u201d PCI. \u00a9 2013 Wiley Periodicals, Inc.<\/jats:p>","DOI":"10.1002\/ccd.22929","type":"journal-article","created":{"date-parts":[[2011,1,13]],"date-time":"2011-01-13T18:44:40Z","timestamp":1294944280000},"source":"Crossref","is-referenced-by-count":35,"title":["The impella recover 2.5 and TandemHeart ventricular assist devices are safe and associated with equivalent clinical outcomes in patients undergoing high\u2010risk percutaneous coronary intervention"],"prefix":"10.1002","volume":"82","author":[{"given":"Jason C.","family":"Kovacic","sequence":"first","affiliation":[{"name":"Cardiac Catheterization Laboratory Cardiovascular Institute Mount Sinai Hospital New York New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huy T.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Cardiac Catheterization Laboratory Cardiovascular Institute Mount Sinai Hospital New York New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rucha","family":"Karajgikar","sequence":"additional","affiliation":[{"name":"Cardiac Catheterization Laboratory Cardiovascular Institute Mount Sinai Hospital New York New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samin K.","family":"Sharma","sequence":"additional","affiliation":[{"name":"Cardiac Catheterization Laboratory Cardiovascular Institute Mount Sinai Hospital New York New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annapoorna S.","family":"Kini","sequence":"additional","affiliation":[{"name":"Cardiac Catheterization Laboratory Cardiovascular Institute Mount Sinai Hospital New York New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,4,8]]},"reference":[{"key":"e_1_2_7_2_1","unstructured":"American Heart Association. Heart Disease and Stroke Statistics\u20142010 Update. Available at:http:\/\/www.americanheart. org\/presenter.jhtml?identifier=1200026. Last accessed 29 January 2011."},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1010-7940(99)00134-7"},{"key":"e_1_2_7_4_1","first-page":"219","article-title":"The SYNTAX Score: An angiographic tool grading the complexity of coronary artery disease","volume":"1","author":"Sianos G","year":"2005","journal-title":"EuroIntervention"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2005.066415"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00267-3"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.11.062"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.108.847137"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2006.02.024"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.03.036"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.21160"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.20380"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.22011"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2006.05.031"},{"key":"e_1_2_7_15_1","first-page":"67","article-title":"Clinical application of prophylactic percutaneous left ventricular assist device (TandemHeart) in high\u2010risk percutaneous coronary intervention using an arterial preclosure technique: Single\u2010center experience","volume":"20","author":"Rajdev S","year":"2008","journal-title":"J Invasive Cardiol"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2008.11.005"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.10.037"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi161"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV4I3A60"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1190"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.09.018"}],"container-title":["Catheterization and Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fccd.22929","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccd.22929","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T22:45:26Z","timestamp":1696632326000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccd.22929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,8]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.1002\/ccd.22929"],"URL":"https:\/\/doi.org\/10.1002\/ccd.22929","archive":["Portico"],"relation":{},"ISSN":["1522-1946","1522-726X"],"issn-type":[{"value":"1522-1946","type":"print"},{"value":"1522-726X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,8]]}}}